If you need more lookups,
subscriptions start at $34 USD/month.
Adam Hooper Location
Metuchen, NJ, US
Adam Hooper Work
Associate Director, Access and Reimbursement- Radioligand Therapy Nuclear Medicine @ (March 2024 - Present)
Associate Director, Access and Reimbursement Neuroscience @ (April 2022 - March 2024)
Field Reimbursement Manager- Neuroscience @ (April 2020 - April 2022)
Field Reimbursement and Market Access Manager Supporting Novartis Neurology @ (February 2018 - April 2020)
Managed Markets and Market Access and Field Reimbursement Manager Supporting Amgen Nephrology @ (October 2016 - February 2018)
Therapeutics and Pain Management @ (May 2016 - October 2016)
Pharmaceutical Sales and Market Access @ (October 2013 - May 2016)
Market Access Representative @ Publicis Touchpoint Solutions Representing Astrazeneca (March 2011 - September 2013)
Client Services @ (December 2010 - March 2011)
Adam Hooper Education
William Paterson University of New Jersey
Adam Hooper Skills
Pharmaceutical Sales
Pharmaceutical Industry
Managed Care
Cardiology
Sales Operations
Sales Effectiveness
Product Launch
Medical Devices
Sales
Diabetes
Account Management
Customer Service
Sales Force Development
Healthcare
Selling Skills
Cold Calling
Biotechnology
Leadership
Training
Microsoft Word
Social Media
PowerPoint
Microsoft Office
Marketing
Market Access
Strategic Planning
Adam Hooper Summary
Adam Hooper, based in Metuchen, NJ, US, is currently a Associate Director, Access and Reimbursement- Radioligand Therapy Nuclear Medicine at Novartis. Adam Hooper brings experience from previous roles at Novartis, Syneos Health Commercial Solutions (Previously inVentiv Health Commercial Soluti and UBC. Adam Hooper holds a William Paterson University of New Jersey. With a robust skill set that includes Pharmaceutical Sales, Pharmaceutical Industry, Managed Care, Cardiology, Sales Operations and more. Adam Hooper has 4 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Adam Hooper?
Find contact details for 700 million professionals.